Artivion (AORT) Stock: Buy, Sell, or Hold?
$20.47
-0.17 (-0.82%)
▼
5d:
-13.67%
30d:
-6.06%
90d:
-28.53%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
36/100
Position
OVERSOLD
30-Day Fair Range
$21.24 – $23.86
Position: OVERSOLD
Forward P/E & Valuation
39.4x
FAIR
vs 36.0x historical avg
Wall Street Target
$38.47
+87.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$19.21 / $27.00
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: AORT is down 13.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$25.32
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.72
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $20.47, which is considered oversold relative to its 30-day fair value range of $21.24 to $23.86. The stock's valuation (Forward PE: 39.4) is in line with its historical norms (36.0). At these levels, the market is pricing in 3.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AORT is in a downtrend. Immediate support is located at $19.20, while resistance sits at $27.00.
Market Sentiment: AORT scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $38.47 (+87.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AORT is in a downtrend. Immediate support is located at $19.20, while resistance sits at $27.00.
Market Sentiment: AORT scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $38.47 (+87.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$21.24 -
$23.86
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
58.1%
Trading Range & Key Levels
30-Day Trading Range
$21.24 -
$23.86
Current vs Trading Range
OVERSOLD
Support Level
$19.21
Resistance Level
$27.00
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding AORT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (22/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 87.9% below Wall St target ($38.47)
- NEUTRAL: Market pricing in 3.0% annual earnings growth - fairly valued
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
39.37
Wall Street Target
$38.47
(+87.9%)
Revenue Growth (YoY)
9.2%
Profit Margin
-3.6%
Valuation Premium vs History
+3.0% premium
PE vs Historical
39.4 vs 36.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.0%
(market-implied from PE analysis)
1-Year Target
$21.08
(+3%)
2-Year Target
$21.72
(+6%)
3-Year Target
$22.37
(+9%)
3-Yr Target (if PE normalizes)
(PE: 39→36)
PE COMPRESSION
$20.46
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 39.4, Growth: 39.9%)
$56.05
(+174%)
Base:
(SPY PE: 19.9, Growth: 39.9%)
$28.28
(+38%)
Bear:
(PE: 16.9, Growth: 39.9%)
$24.03
(+17%)
Share AORT Analysis
Share this live AORT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AORT)
Bullish
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
May 8, 2026
Daily AI digest
AI Retail Discussion Summary:
Artivion (AORT) reported Q1 earnings and revenues surpassing estimates, leading to bullish sentiment on StockTwits.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AORT Research Pages
